The Faustman Laboratory at Massachusetts General Hospital in the United States is currently conducting a Phase II clinical trial testing the ability of BCG to reverse type 1 diabetes.
Multiple Sclerosis
The Ristori lab at Sapienza University of Rome, Italy, is conducting at Phase II trial of BCG in multiple sclerosis.